# List of the training PDF files

Some of these files are confidential, but the ones which are not confidential are downloadable by the `download-raw-protocols.sh` script.

EDD-Cholera-2016-Qadri-Shanchol.pdf
EDD-R-2017-G-V.pdf
EDD-rotavirus-2017-Isanaka-ROSE.pdf
EDD-T-2019-S-T.pdf
HIV-HIV-2016-Ayles-A Study of the HIV prevention Trials Network.pdf
HIV-HIV-2016-Garrett-HVTN108.pdf
HIV-HIV-2016-HVTN114.pdf
HIV-HIV-2016-Kurth-High-yield HIV testing, facilitated linkage to care.pdf
HIV-HIV-2016-Laufer-Trimethoprim-Sulfamethoxazole-Chloroquine.pdf
HIV-HIV-2016-N-S.pdf
HIV-HIV-2016-R-E.pdf
HIV-HIV-2016_Tebas-A5354.pdf
HIV-HIV-2016-Weinberg-NICHP1091.pdf
HIV-HIV-2017-Abrams-IMPAACT P1101.pdf
HIV-HIV-2017-Bekker-HVTN100.pdf
HIV-HIV-2017-Corey-HVTN703-HPTN081.pdf
HIV-HIV-2017-Corey-HVTN704-HPTN085.pdf
HIV-HIV-2017-Evolocumab-AMG145.pdf
HIV-HIV-2017-L-I.pdf
HIV-HIV-2018-GSK1265744.pdf
HIV-HIV-2018-Havlir-SEARCH.pdf
HIV-HIV-2018-IMPAACT-P1112.pdf
HIV-HIV-2018-Labhardt-CASCADE.pdf
HIV-HIV-2018-Lockman-Dolutegravir-Containing versus Efavirenz-Containing Antiretroviral Therapy.pdf
HIV-HIV-2018-Long-acting Cabotegravir Plus Long-acting Rilpivirine.pdf
HIV-HIV-2018-M-A.pdf
HIV-HIV-2019-H-S.pdf
HIV-HIV-2019-K-C.pdf
HIV-HIV-2019-Venter-ADVANCE.pdf
MAL-M-2018-D-C.pdf
MAL-M-2019-A-S.pdf
MAL-MAL-2018-Dorsey-PROMOTE Birth Cohort 1.pdf
MAL-Malaria-2016-Valencia-Phase 1 and 2a Clinical.pdf
MAL-Malaria-2019-Foy-RIMDAMAL.pdf
MAL-Malaria-2019-Llanos-Cuentas-Tafenoquine vs. Primaquine to.pdf
MAL-Malaria-2019-Tinto-Extension to study MALARIA-055 PRI.pdf
MAT-Anemia-2015-Etheredge-Prenatal Iron Supplements Safety and.pdf
MAT-Cervical Disease-2019-Greene-LEEP.pdf
MAT-HIV-2016-Fowler-PROMISE.pdf
MAT-Hypothermia-2018-Hansen-Electricity-free Infant Warmer.pdf
MAT-MAT-2018-G-F.pdf
MAT-V-2018-R-M.pdf
NTD-Chagas-2015-Morillo-BENEFIT.pdf
NTD-D-2017-S-P.pdf
NTD-E-2017-A-A.pdf
NTD-Filariasis-2019-Weil-DOLF IDA Haiti.pdf
NTD-Filariasis-2019-Weil-DOLF IDA Indonesia.pdf
NTD-Filariasis-2019-Weil-DOLF IDA Papua New Guinea.pdf
NTD-Hookwork-2018-Keiser-Efficacy and safety of a single.pdf
NTD-t-2017-M-E.pdf
NTD-Y-2019-M-Y.pdf
NUT-A-2019-M-T.pdf
NUT-NUT-2019-A-I.pdf
NUT-S-2018-L-W.pdf
NUT-S-2018-R-S.pdf
NUT-Stunting-2019-Humphrey-SHINE.pdf
PNE-P-2019-C-P.pdf
PNE-Pneumonia-2018-Keenan-Mortality Reduction After Oral Azithromycin.pdf
PNE-Pneumonia-2019-Alexander-LEAP2.pdf
POL-P-2016-G-T.pdf
POL-P-2018-O-A-L.pdf
TB-TB-2015-D-A.pdf
TB-TB-2018-Churchyard-Bedaquiline-Delamanid.pdf
TB-TB-2018-DAR-PIA.pdf
TB-TB-2018-H-A.pdf
TB-TB-2018-M-P-A.pdf
TB-TB-2018-Piazza-A Phase 1b, Randomized, Double-blind.pdf
TB-TB-2019-Dawson-A Phase 2 Open‚ÄêLabel Partially .pdf
TB-TB-2019-M-A.pdf
TB-TB-2019-N-S.pdf
TB-TB-2019-Suliman-A Phase I_IIa Double-Blind.pdf
TB-TB-2019-T-A-b.pdf
TB-TB-2020-John-Stewart-iTIPS.pdf
VAC-Ecoli-2019-Qadri-ETVAX.pdf
VAC-G-2016-VAC-G-2016-V.pdf
VAC-M-2015-L-W.pdf
VAC-Shigellosis-2019-Raqib-Shigella WRSS1 Vaccine trial in Bangladesh.pdf
VAC-Tdap-2019-Sancovski-A Post-marketing, Observational, Retrospective.pdf
